home   about   contact   links
MPT WWW
 
 

August 31, 2007

Doctors to Washington: Your Rules Don't Make Sense

Cancer docs appealed to Medicare this week to relax controversial rules that limit their ability to prescribe anemia drugs to their patients:

An official with the American Society of Clinical Oncology, a powerful lobby of cancer doctors, said they will formally ask that the U.S. Centers for Medicare and Medicaid re-open a final rule issued last month tightening usage and dosing for the drugs.

The erythropoiesis-stimulating agents are sold by Amgen Inc. as Epogen and Aranesp, and by Johnson & Johnson as Procrit, and are also known as EPO drugs.

"The proposal is unworkable and there is no evidence to support it at all," said Joseph Bailes, chair of the government relations panel at the American Society of Clinical Oncologists and a medical oncologist practicing in Houston.

This illustrates why, as Regina Herzlinger argues, Uncle Sam makes a bad doctor: federal agencies are driven to make knee jerk, cookie-cutter decisions that distort health outcomes.


Posted by Paul Howard at August 31, 2007 11:52 AM

PRINT PAGE | EMAIL PAGE
 
IN THE SPOTLIGHT:
Free-Market Medicine
by Paul Howard, Ph.D.
August 20, 2008

FORUM

COMMENTARY

RESEARCH

Medical Progress

Intellectual Property
Rights & Innovation

Global Health & Bio-terrorism

Prescriptions for Policy

  
home   spotlight   commentary   research   events   news   about   contact   links   archives
Copyright Manhattan Institute for Policy Research
52 Vanderbilt Avenue
New York, NY 10017
(212) 599-7000
mpt@manhattan-institute.org